Average Brokerage Recommendation for Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics reports 4Q16 Loss Confined; Beats Street View

Celldex Therapeutics reports 4Q16 Loss Confined; Beats Street View

The last session's volume of 4.10 million shares was higher than its average volume of 1.93 million shares. Dimensional Fund Advisors LP raised its position in shares of Celldex Therapeutics, Inc. The research firm Initiated the stock to Buy. Other firms include Jefferies giving Hold rating on 8-Mar-16.

03/07/2016 - Celldex Therapeutics, Inc. was downgraded to "market perform" by analysts at Leerink Swann.

05/09/2016 - Celldex Therapeutics, Inc. had its "neutral" rating reiterated by analysts at Wedbush. Over the 52-week time span, the stock notched a high price of $5.13 and its minimum price was $2.85. Full-year profit views are for Celldex Therapeutics, Inc.to earn -$1.31 in current year and drop profits by almost 0% over last year's earnings of -$1.31.

The company's stock now has 414.62 Million in market capitalization. They now have a United States dollars 4 price target on the stock. The companys lead drug candidates comprise Rintega (CDX-110), a therapeutic vaccine in Phase III clinical studies for the treatment of glioblastoma patients that express an epidermal growth factor receptor variant III, as well as in Phase II study for the treatment of recurrent glioblastoma; Glembatumumab vedotin (CDX-011), a targeted antibody-drug conjugate (ADC) in a randomized Phase IIb study for the treatment of triple negative breast cancer, as well as in Phase II study for the treatment of metastatic melanoma; and Varlilumab (CDX-1127), an immune modulating antibody is in Phase I study for the treatment of multiple solid tumors. NASDAQ:CLDX may hit a high of $10. The stock now has an average rating of "Buy" and an average price target of $7.63.

Celldex Therapeutics, Inc. has a 50 day moving average of 3.43 and a 200 day moving average of 3.66.

In the past 6 months, 5 Insider purchases and 1 Insider Sales were made in which 25800 shares were traded as Insider purchases and 25000 shares were exchanged as Insider Sales. The biopharmaceutical company reported ($0.30) earnings per share for the quarter, topping the consensus estimate of ($0.34) by $0.04.

Top line figures for the fourth quarter rose 4% to $ 1.87 million from $ 1.79 million in the same quarter previous year, where as analysts anticipated $ 1.08 million.

When we look at the recommendation trends, the stock presently has an average brokerage recommendation of 1.6. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock.

The analysts offering 12 month price targets for Celldex Therapeutics, Inc. have a median target of $7, with a high estimate of $10 and a low estimate of $4. FMR LLC now owns 19,327,111 shares of the biopharmaceutical company's stock valued at $68,418,000 after buying an additional 5,555,595 shares in the last quarter. This showed the surprise of 11.8% in the last quarter earnings.

Profitability analysis helps a great deal in making investment decision. Price per earning (ttm) stands at 0.

More analysts at Reuters have a buy or better ratings (5) on the Celldex Therapeutics, Inc. stock than those who have a hold (3) rating while the 12-month target price suggested by the average analysts is $7.5. The most recent short interest data show 15.8% of the company's stock are short sold.

Recommended News

  • Highly-venomous cobra escapes Florida home; residents panic

    Highly-venomous cobra escapes Florida home; residents panic

    Some people here are too scared to be in their own homes, fearing about not knowing where the venomous snake might be hiding. It hasn't been seen since and officials say they aren't sure if it's actually escaped the home.

    2 teens found dead in vehicle in St. Charles

    Deputy Police Chief David Kintz said the bodies of a man and woman were found in the back seat of a auto off 17th Street in St. Those in the auto have been identified as Adalina Elizabeth Donoso, 18, of Racine, Wis., and Kody R.
    Roger Stone Reportedly in Car Accident

    Roger Stone Reportedly in Car Accident

    The Broward County Sheriff's Office did not respond immediately to The Washington Post's request for comment late Wednesday night. But the immediate issue of Russian influence or collusion with the Trump campaign brings several suspected parties to the fore.
  • Q1 2017 EPS Estimates for TG Therapeutics Inc Lowered by Analyst (TGTX)

    One research analyst has rated the stock with a sell rating and eight have issued a buy rating to the company's stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website .

    Antofagasta PLC reiterated as Underweight By JP Morgan

    In an analyst rating update on Thursday shares of Antofagasta PLC (LON:ANTO) had their rating reiterated by analysts at JP Morgan. The shares were bought at an average cost of GBX 211 ($2.58) per share, with a total value of £1,266,000 ($1,547,866.49).
    Microsoft Surface Book 2 Is Set for Immature Release Date?

    Microsoft Surface Book 2 Is Set for Immature Release Date?

    Meanwhile, the Surface Pro 4 price cut also suggests that the company is already planning to release the Microsoft Surface Pro 5. Microsoft is reportedly preparing to launch the successor of Surface Pro 4, the Microsoft Surface Pro 5 this year.
  • Windows 10 Creators Update Might Be Released Next Week

    Windows 10 Creators Update Might Be Released Next Week

    For example, user with the right permissions will be able to pause a feature update while allowing quality updates to continue. Windows Vista now has less than 1 percent global market share in terms of PC operating systems, according to Net Applications.
    Torrance high school baseball player killed in car crash

    Torrance high school baseball player killed in car crash

    A 21-year-old man was arrested on suspicion of vehicular manslaughter. "It's incredibly tragic", Coach Grady Sain said. Police are searching for the identity of a second driver, who fled the scene, according to the Daily Breeze .
    Strep throat leads to amputation of MI  man's hands and feet

    Strep throat leads to amputation of MI man's hands and feet

    That initial diagnosis was due to Breen's symptoms as his stomach began to grow and harden. "He was very susceptible to it", Dr. Breen is one of two men in the world who had strep travel from his throat to stomach, according to Steensma.
  • Aug man's death ruled a homicide; Investigators looking into dead roommate's vehicle

    Canard was making a left turn onto Hastings Road when a motorcycle going quickly smashed into the side of his vehicle. The auto rolled over after the impact, throwing Canard out.
    Le'Veon Bell barred from attending Steelers fan's prom

    Le'Veon Bell barred from attending Steelers fan's prom

    Tarantino's father, Jim, hopes they can work something out with the school and said Thursday that she had filed her request. And when she surpassed that - she has since hit 2,000-plus - he tweeted, "A deal is a deal. see you at your prom".
    April the Giraffe's vet suggests movement for birthing

    April the Giraffe's vet suggests movement for birthing

    This will be April's fourth calf and the first for the father, Oliver. April the Giraffe continued to remain in her current condition. That means the baby is moving into place for birth.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.